会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明公开
    • Peptidylaminodiols
    • EP0189203A3
    • 1989-08-23
    • EP86100917.3
    • 1986-01-23
    • ABBOTT LABORATORIES
    • Luly, Jay RichardPlattner, John JacobRosenberg, Saul HowardFung, Anthony K.L.
    • C07K5/06C07D233/64A61K37/64
    • C07K5/06078A61K38/00C07K5/0227C07K5/06017C07K5/06139Y02P20/55
    • The invention relates to renin inhibiting compounds of the formula:
      wherein R 10 is
      A is hydrogen or an N-protecting group; w is 0 or 1; B is hydrogen, hydroxy, NH, N-alkyl, loweralkyl or arylalkyl; with the proviso that when w is 1, B is NH and when w is 0, B is hydrogen, hydroxy, loweralkyl or arylalkyl; R 1 is loweralkyl or lipophilic or aromatic or hydrophilic amino acid side chains; m is 1-3; n is 1-3; p is 1-3; q is 1-3; s is 1-3; t is 0-2; R 2 is hydrogen or loweralkyl; R 3 and R 4 are independently selected from loweralkyl, lipophilic or aromatic amino acid side chains; R 5 and R 7 are independently selected from hydrogen or loweralkyl; and R 6 is hydrogen, loweralkyl, vinyl, arylalkyl or wherein R 8 is hydrogen or loweralkyl, X is O, NH or S and R 9 is hydrogen, loweralkyl or alkanoyl or XR 9 together can be loweralkylsulfonyl, N 3 or Cl.
    • 本发明涉及下式的肾素抑制化合物:其中R 10是A是氢或N-保护基; w是0或1; B是氢,羟基,NH,N-烷基,低级烷基或芳基烷基; 条件是当w为1时,B为NH且当w为0时,B为氢,羟基,低级烷基或芳基烷基; R1是低级烷基或亲脂性或芳族或亲水性氨基酸侧链; m是1-3; n是1-3; p是1-3; q是1-3; s是1-3; t是0-2; R2是氢或低级烷基; R3和R4独立地选自低级烷基,亲脂性或芳族氨基酸侧链; R5和R7独立地选自氢或低级烷基; 且R6为氢,低级烷基,乙烯基,芳基烷基或其中R8为氢或低级烷基,X为O,NH或S且R9为氢,低级烷基或烷酰基或XR9一起可为低级烷基磺酰基,N3或Cl。
    • 2. 发明公开
    • Peptidylaminodiols
    • Peptidylaminodiole。
    • EP0189203A2
    • 1986-07-30
    • EP86100917.3
    • 1986-01-23
    • ABBOTT LABORATORIES
    • Luly, Jay RichardPlattner, John JacobRosenberg, Saul HowardFung, Anthony K.L.
    • C07K5/06C07D233/64A61K37/64
    • C07K5/06078A61K38/00C07K5/0227C07K5/06017C07K5/06139Y02P20/55
    • The invention relates to renin inhibiting compounds of the formula:
      wherein R 10 is
      A is hydrogen or an N-protecting group; w is 0 or 1; B is hydrogen, hydroxy, NH, N-alkyl, loweralkyl or arylalkyl; with the proviso that when w is 1, B is NH and when w is 0, B is hydrogen, hydroxy, loweralkyl or arylalkyl; R 1 is loweralkyl or lipophilic or aromatic or hydrophilic amino acid side chains; m is 1-3; n is 1-3; p is 1-3; q is 1-3; s is 1-3; t is 0-2; R 2 is hydrogen or loweralkyl; R 3 and R 4 are independently selected from loweralkyl, lipophilic or aromatic amino acid side chains; R 5 and R 7 are independently selected from hydrogen or loweralkyl; and R 6 is hydrogen, loweralkyl, vinyl, arylalkyl or wherein R 8 is hydrogen or loweralkyl, X is O, NH or S and R 9 is hydrogen, loweralkyl or alkanoyl or XR 9 together can be loweralkylsulfonyl, N 3 or Cl.
    • 本发明涉及下式的肾素抑制化合物:其中R 10是氢或N-保护基; w为0或1; B是氢,羟基,NH,N-烷基,低级烷基或芳基烷基; 条件是当w为1时,B为NH,当w为0时,B为氢,羟基,低级烷基或芳基烷基; R1是低级烷基或亲脂性或芳族或亲水氨基酸侧链; m为1-3; n为1-3; p为1-3; q为1-3; s是1-3; t为0-2; R2是氢或低级烷基; R3和R4独立地选自低级烷基,亲脂性或芳族氨基酸侧链; R5和R7独立地选自氢或低级烷基; 并且R 6是氢,低级烷基,乙烯基,芳烷基或其中R 8是氢或低级烷基,X是O,NH或S,R 9是氢,低级烷基或烷酰基或X R 9一起可以是低级烷基磺酰基,N 3或Cl。